
SICRES Hosts the International Clinical Trial Center Network (ICN) 2026 Meetings
Welcome International Clinical Research Network Members for Knowledge Exchange and an Experience of Bangkok’s Charm on 11-12 November 2026

CREST 2026 Successfully Concludes with Strong Multi-Stakeholder Collaboration
The Siriraj Institute of Clinical Research (SICRES), Faculty of Medicine Siriraj Hospital, Mahidol University, successfully hosted CREST 2026 on 13 November 2026 at The Sukosol Hotel Bangkok, Thailand.

Thailand Becomes the World’s Second Country to Approve NUZOLVENCE® (zoliflodacin)
Celebrating a Major Milestone in the Global Fight Against Antimicrobial Resistance

Thailand Achieves First Patient Enrollment Outside Japan in the ABLe Study
Thailand Achieves First Patient Enrollment Outside Japan in the ABLe Study

“Thailand Clinical Research Hub” ระดมทุกภาคส่วนขับเคลื่อนประเทศไทยสู่ศูนย์กลางการวิจัยทางคลินิกระดับภูมิภาค
งานเสวนาวิชาการในหัวข้อ “Thailand Clinical Research Hub: Aligning Clinical Research Capacity with New Growth Engine Policy”

ขอน้อมส่งเสด็จสู่สวรรคาลัย
ขอน้อมส่งเสด็จสู่สวรรคาลัยสมเด็จพระเจ้าลูกเธอ เจ้าฟ้าพัชรกิติยาภา นเรนทิราเทพยวดี กรมหลวงราชสาริณีสิริพัชร มหาวัชรราชธิดา

Download now! Clinical Study Coordinator: Hands-on Training
Ready to download Now! ICH GCP R3 (Good Clinical Practice) Training Certificate organized by Siriraj Institute of Clinical Research

A Successful Global Trial Paves the Way for the US FDA Approval of the First-in-Class Gonorrhoea Antibiotic
A major milestone in global health has been achieved with the U.S. FDA approval of NUZOLVENCE® (zoliflodacin), the first new antibiotic developed exclusively for the treatment of gonorrhoea in decades.
- +66 2 414 1914, +66 2 414 1899
- [email protected]
- 10th floor, Siriraj Medical Research Center (SiMR) , Siriraj Hospital
- Bangkok Noi, Bangkok, THAILAND
- Copyright © SICRES. All rights reserved.